- Home
- VTVT vs MNSB Comparison
VTVT vs MNSB Comparison
Compare VTVT & MNSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VTVT | MNSB |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.0M | 148.8M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | VTVT | MNSB |
|---|---|---|
| Price | $33.54 | $21.20 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $51.33 | N/A |
| AVG Volume (30 Days) | 21.5K | ★ 29.0K |
| Earning Date | 11-06-2025 | 01-27-2026 |
| Dividend Yield | N/A | ★ 1.98% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $17,000.00 | ★ $69,367,000.00 |
| Revenue This Year | N/A | $21.22 |
| Revenue Next Year | N/A | $3.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 9.71 |
| 52 Week Low | $13.46 | $15.00 |
| 52 Week High | $44.00 | $22.98 |
Technical Indicators
Market Signals| Indicator | VTVT | MNSB |
|---|---|---|
| Relative Strength Index (RSI) | 46.49 | 62.40 |
| Support Level | $31.80 | $19.77 |
| Resistance Level | $41.95 | $20.68 |
| Average True Range (ATR) | 3.40 | 0.60 |
| MACD | -1.05 | 0.03 |
| Stochastic Oscillator | 19.44 | 86.43 |
Price Performance
Historical ComparisonAbout VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin, currently in a Phase 3 trial, a potential novel first-in-class oral liver-selective glucokinase activator being investigated for the treatment of type 1 diabetes. The group and its development partners are investigating multiple molecules across different indications for chronic diseases. Its product pipeline are HPP737, Azeliragon, TTP-RA, TTP273, HPP971 / HPP3033, and HPP593.
About MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.